DR AGARWALS HEALTH CARE LIMITED
Price Band
₹ 382 - ₹ 402
Bid Lot
35 Shares
DR AGARWALS HEALTH CARE LIMITED
29-Jan-2025 - 31-Jan-2025
Price Band
₹ 382 - ₹ 402
Minimum Investment
₹ 14070.00
Bid Lot
35 Shares
Shares
75,304,930
-
Face Value - Rs. 1/- Per Share
- Lisitng at NSE BSE
-
725,959 Application Required in Retail for 1 Time.
-
Registrar :
KFin Technologies Limited
IPO Details
Fresh Issue of Equity Shares aggregating up to Rs. 300 Cr + Offer for Sale of up to 67,842,284 Equity Shares
QIB
50%
(36,297,998 Shares)RS.1459.18 CR
HNI 1
5%
(3,629,800 Shares)RS.145.92 CR @ 6914 FORM 1X
HNI 2
10%
(7,259,600 Shares)RS.291.84 CR @ 13828 FORM 1X
Retail
35%
(25,408,599 Shares)RS.1021.43 CR @ 725960 FORM 1X
Employee
0%
(1,579,399 Shares)RS.63.49 CR
ShareHolder
0%
(1,129,574 Shares)RS.45.41 CR
BRLMs: Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, Motilal Oswal Investment Advisors
Timeline
-
29
Jan-2025
Open Date
-
31
Jan-2025
Close Date
-
03
Feb-2025
Basis of Allotment Date
-
04
Feb-2025
Initiation of Refunds
-
04
Feb-2025
Credit of Shares to Demat A/C
-
04
Feb-2025
IPO Listing Date
Subscription as on 31-Jan-2025 17:37
Category
Book Size
Subscription
QIB
4.64x
14,519,184
(₹583.67 Cr.)
67,361,280
(₹2707.92 Cr.)
HNI (<10 LAKH)
0.55x
3,629,800
(₹145.92 Cr.)
1,994,580
(₹80.18 Cr.)
HNI2 (>10 LAKH)
0.31x
7,259,600
(₹291.84 Cr.)
2,285,955
(₹91.90 Cr.)
RETAIL
0.41x
25,408,599
(₹1021.43 Cr.)
10,342,430
(₹415.77 Cr.)
EMP
0.27x
1,579,399
(₹63.49 Cr.)
419,510
(₹16.86 Cr.)
SHA
0.51x
1,129,574
(₹45.41 Cr.)
576,765
(₹23.19 Cr.)
Total
1.55x
53,526,156
82,980,520
Category
Book Size
Subscription
QIB
4.64x
14,519,184
(₹583.67 Cr.)
67,361,280
(₹2707.92 Cr.)
HNI (<10 LAKH)
0.55x
3,629,800
(₹145.92 Cr.)
1,994,580
(₹80.18 Cr.)
HNI2 (>10 LAKH)
0.31x
7,259,600
(₹291.84 Cr.)
2,285,955
(₹91.90 Cr.)
RETAIL
0.41x
25,408,599
(₹1021.43 Cr.)
10,342,430
(₹415.77 Cr.)
EMP
0.27x
1,579,399
(₹63.49 Cr.)
419,510
(₹16.86 Cr.)
SHA
0.51x
1,129,574
(₹45.41 Cr.)
576,765
(₹23.19 Cr.)
Total
1.55x
53,526,156
82,980,520
*Excluding Anchor
Total No. of Application Approx : ~245524 (0.34 Appwise)
HNI Cost
About Company
-
The Company was incorporated as ‘Dr. Agarwal’s Health Care Ltd’ at Chennai, Tamil Nadu as a public Ltd company in April 2010. The company provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells opticals, contact lens and accessories, and eye care related pharmaceutical products.
-
Dr. Agarwal’s Health Care is India’s largest eye care service chain by revenue from operations for the FY 2024, with ~ 1.7 times the revenue from operations of the second- largest eye care service chain in the country. The company had a market share of ~ 25% of the total eye care service chain market in India during the FY 2024.
-
As of September 30, 2024, the company had 737 doctors, who specialize in multiple super-specialties, including, cataract, cornea, retinal and refractive surgery, glaucoma, oculoplasty, and neuro-ophthalmology, among others.
-
During FY 2024, the company served 2.13 million patients and performed 220,523 surgeries, while for 6 months ended September 30th, 2024, the company served 1.15 million patients and performed 140,787 surgeries.
-
The company provides a comprehensive range of eye care services through a network of Facilities. As of September 30, 2024, the company had 193 Facilities in India spanning 14 states and 4 union territories, and 16 Facilities spread across 9 countries in Africa.
-
The company’s Facilities have received national and international accreditations, such as from the National Accreditation Board for Hospitals and Healthcare Providers (the “NABH”). As of December 2024, the company had the highest number of NABH-accredited eye care facilities with 29 accredited eye care facilities.
-
The company’s Revenue from Operations grew to ? 1,332.15 Cr for the FY 2024 from ? 696.08 million for the 2022. The EBITDA increased to ? 406.56 Cr for FY 2024 from ? 199.82 Cr for FY 2022. As of September 30, 2024, the company’s debt-to-equity ratio was 0.66x, as against 0.70 x in FY2024 and 2.71x as of March 31, 2022. The company is the only specialty eye care service provider to experience an increase in its operating profit margin from the FY 2023 to 2024.
Strengths
Competitive Strength
-
Largest eye care services provider in India with a trusted brand
-
End-to-end, comprehensive eyecare services offering
-
Scalable, asset-light, hub-and-spoke operating model
-
Proven clinical excellence driven by a strong clinical board and history of surgical innovations
-
Doctor-promoters leading a team of qualified medical professionals and supported by an experienced management
-
Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability
Business Strategies
-
Continued organic expansion of the network in India
-
Strengthen the brand equity with community, patients, and doctors across India
-
Undertake opportunistic acquisitions and restructuring to scale the operations, leveraging the experience of inorganic growth and integration
-
Attracting and retaining qualified doctors and paramedics through continuous training, knowledge sharing and upskilling
-
Focus on improving profitability and Facility-level growth and enhancing operational efficiencies
Company Promoters
Company Financials
Dr. Agarwal's Health Care Limited Financial Information (Restated Consolidated)
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 | ||||||||||||||||||||||||||||||||||||
| Revenue | 837.94 | 1,376.45 | 1,031.49 | 713.78 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 1,509.11 | 1,365.86 | 652.63 | 236.27 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 | ||||||||||||||||||||||||||||||||||||
| Amount in ? Crore | ||||||||||||||||||||||||||||||||||||||||
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
- Repayment/prepayment, in part or full, of certain of the borrowings and
- General corporate purposes and unidentified inorganic acquisition.
How to Apply
Apply for IPO in few simple steps.
-
Step 1
Once you create your account, Login to Easy Investing.
-
Step 2
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
-
Step 3
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
-
Step 4
Enter your UPI ID and you will receive mandate on your UPI App.
-
Step 5
Once you accept the mandate, Application is submitted successful.
The Bidding Process
- Applying for an IPO is easier than ever with Easy Investing, in just a few clicks your application is processed. You can bid for any IPO through Easy Investing, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
- If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
- The maximum subscription amount for retail investors is 2 lakh.
- Any bid can be at a desired price or cut off price given by the company.
How to bid on App?
- Enter the number of shares you wish to buy, as per the lot size.
- You can apply at the cut off price set by the company or bid for a desired amount within the price band.
- Maximum three bids will be accepted.
- You then need to enter the UPI ID on Easy Investing’s IPO application form.
Investing using UPI
- You will immediately get a fund blocked request on your UPI for the submitted IPO application.
- The funds will be blocked in your bank account until allotment when it is debited.
- The limit for IPO application is Rs 2 lakh per transaction on UPI.
- On allotment of the shares, the money will be automatically debited.
- If the share aren’t allotted the blocked funds will reflect back into your account.
FAQs